REMEDY PHARM LIMITED Small abbreviated accounts

REMEDY PHARM LIMITED - Company Information

FY Private Limited Company Company accounts 2017-07-31 2017-07-31 false true false false false false false false false false false false true true 2015-11-01 true xbrli:pure xbrli:shares iso4217:GBP 07047236 2015-11-01 2016-10-31 07047236 2016-10-31 07047236 2015-10-31 07047236 2015-10-31 07047236 uk-gaap:FixturesFittings 2015-11-01 2016-10-31 07047236 uk-gaap:MotorVehicles 2015-11-01 2016-10-31 07047236 uk-gaap:NetGoodwill 2015-11-01 2016-10-31 07047236 uk-bus:EntityAccountantsOrAuditors uk-bus:PrincipalAgent 2015-11-01 2016-10-31 07047236 uk-bus:OrdinaryShareClass1 2015-11-01 2016-10-31 07047236 uk-bus:Director1 2015-11-01 2016-10-31 07047236 uk-gaap:AllSubsidiaries 2015-11-01 2016-10-31 07047236 uk-bus:EntityAccountantsOrAuditors uk-bus:PrincipalAgent 2016-10-31 07047236 uk-bus:OrdinaryShareClass1 2016-10-31 07047236 uk-bus:OrdinaryShareClass1 2015-10-31 07047236 uk-lang:English 2015-11-01 2016-10-31 07047236 uk-curr:PoundSterling 2015-11-01 2016-10-31

COMPANY REGISTRATION NUMBER 07047236

REMEDY PHARM LIMITED

ABBREVIATED ACCOUNTS

31 October 2016

JOHAL & COMPANY ACCOUNTANTS LTD

Chartered Accountants & Registered Auditors

167 Uxbridge Road

Hanwell

London

W7 3TH

REMEDY PHARM LIMITED

ABBREVIATED BALANCE SHEET

31 October 2016

		2016		2015
Note		£	£	£
FIXED ASSETS	2
Intangible assets			246,167	292,167
Tangible assets			5,488	5,760
			----------	----------
			251,655	297,927
			----------	----------

CURRENT ASSETS

Stocks	32,550		41,995
Debtors	188,732		112,841
Cash at bank and in hand	45,919		89,178
	----------		----------
	267,201		244,014
CREDITORS: Amounts falling due within one year	108,656		124,015
	----------		----------
NET CURRENT ASSETS		158,545	119,999
		----------	----------
TOTAL ASSETS LESS CURRENT LIABILITIES		410,200	417,926

CREDITORS: Amounts falling due after more than one year	379,803	413,625
	----------	----------
	30,397	4,301
	----------	----------

CAPITAL AND RESERVES

Called up equity share capital	3	2	2
Profit and loss account		30,395	4,299
		---------	-------
SHAREHOLDERS' FUNDS		30,397	4,301
		---------	-------

For the year ended 31 October 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These abbreviated accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.

These abbreviated accounts were approved and signed by the director and authorised for issue on 31 July 2017 .

Mr K Ismail Director

Company Registration Number: 07047236

REMEDY PHARM LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS

YEAR ENDED 31 OCTOBER 2016

1. ACCOUNTING POLICIES

Basis of accounting

The financial statements have been prepared under the historical cost convention, and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover

The turnover shown in the profit and loss account represents amounts invoiced during the year, exclusive of Value Added Tax.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:

Goodwill-10 years straight line

Fixed assets

All fixed assets are initially recorded at cost.

Depreciation

Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:

Fixtures & Fittings-20% reducing balance

Motor Vehicles-20% reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

2. FIXED ASSETS

Intangible Assets	Tangible Assets	Total
£	£	£

COST

At 1 November 2015	460,000	12,789	472,789
Additions	–	1,100	1,100
	----------	---------	----------
At 31 October 2016	460,000	13,889	473,889
	----------	---------	----------

DEPRECIATION

At 1 November 2015	167,833	7,029	174,862
Charge for year	46,000	1,372	47,372
	----------	-------	----------
At 31 October 2016	213,833	8,401	222,234
	----------	-------	----------

NET BOOK VALUE

At 31 October 2016	246,167	5,488	251,655
	----------	-------	----------

At 31 October 2015	292,167	5,760	297,927
	----------	-------	----------

3. SHARE CAPITAL

Allotted, called up and fully paid:

	2016		2015
	No.	£	No.	£
Ordinary shares of £ 1 each	2	2	2	2
	----	----	----	----

REMEDY PHARM LIMITED

ACCOUNTANTS' REPORT TO THE DIRECTOR OF REMEDY PHARM

LIMITED

YEAR ENDED 31 OCTOBER 2016

As described on the balance sheet, the director of the company is responsible for the preparation of the abbreviated accounts for the year ended 31 October 2016, which comprise the Balance Sheet and the related notes.

You consider that the company is exempt from an audit under the Companies Act 2006.

In accordance with your instructions we have compiled these unaudited abbreviated accounts in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.

JOHAL & COMPANY ACCOUNTANTS LTD Chartered Accountants & Registered Auditors

167 Uxbridge Road Hanwell London W7 3TH

31 July 2017